205 related articles for article (PubMed ID: 30427124)
41. Renin-angiotensin-aldosterone system inhibitors and SARS-CoV-2 infection: an analysis from the veteran's affairs healthcare system.
Sandhu AT; Kohsaka S; Lin S; Woo CY; Goldstein MK; Heidenreich PA
Am Heart J; 2021 Oct; 240():46-57. PubMed ID: 34126079
[TBL] [Abstract][Full Text] [Related]
42. Prevalence of Angiotensin II Type 1 Receptor Antibodies in Persons With Hypertension and Relation to Blood Pressure and Medication.
Philogene MC; Han D; Alvarado F; Fedarko NS; Zonderman AB; Evans MK; Crews DC
Am J Hypertens; 2020 Aug; 33(8):734-740. PubMed ID: 32330222
[TBL] [Abstract][Full Text] [Related]
43. Resistant Hypertension On Treatment (ResHypOT): sequential nephron blockade compared to dual blockade of the renin-angiotensin-aldosterone system plus bisoprolol in the treatment of resistant arterial hypertension - study protocol for a randomized controlled trial.
Cestário EDES; Fernandes LAB; Giollo-Júnior LT; Uyemura JRR; Matarucco CSS; Landim MIP; Cosenso-Martin LN; Tácito LHB; Moreno H; Vilela-Martin JF; Yugar-Toledo JC
Trials; 2018 Feb; 19(1):101. PubMed ID: 29433578
[TBL] [Abstract][Full Text] [Related]
44. A European Renal Best Practice (ERBP) position statement on the Kidney Disease: Improving Global Outcomes (KDIGO) clinical practice guideline for the management of blood pressure in non-dialysis-dependent chronic kidney disease: an endorsement with some caveats for real-life application.
Verbeke F; Lindley E; Van Bortel L; Vanholder R; London G; Cochat P; Wiecek A; Fouque D; Van Biesen W
Nephrol Dial Transplant; 2014 Mar; 29(3):490-6. PubMed ID: 24071661
[TBL] [Abstract][Full Text] [Related]
45. Clinical Pharmacology of Antihypertensive Therapy for the Treatment of Hypertension in CKD.
Sinha AD; Agarwal R
Clin J Am Soc Nephrol; 2019 May; 14(5):757-764. PubMed ID: 30425103
[TBL] [Abstract][Full Text] [Related]
46. A comparison between angiotensin converting enzyme inhibitors and angiotensin receptor blockers on end stage renal disease and major adverse cardiovascular events in diabetic patients: a population-based dynamic cohort study in Taiwan.
Wu LS; Chang SH; Chang GJ; Liu JR; Chan YH; Lee HF; Wen MS; Chen WJ; Yeh YH; Kuo CT; See LC
Cardiovasc Diabetol; 2016 Apr; 15():56. PubMed ID: 27039185
[TBL] [Abstract][Full Text] [Related]
47. Treatment Patterns and Blood Pressure Control With Initiation of Combination Versus Monotherapy Antihypertensive Regimens.
An J; Luong T; Qian L; Wei R; Liu R; Muntner P; Brettler J; Jaffe MG; Moran AE; Reynolds K
Hypertension; 2021 Jan; 77(1):103-113. PubMed ID: 33190560
[TBL] [Abstract][Full Text] [Related]
48. Antihypertensive agent utilization patterns among patients with uncontrolled hypertension in the United States.
LaVallee C; Rascati KL; Gums TH
J Clin Hypertens (Greenwich); 2020 Nov; 22(11):2084-2092. PubMed ID: 32951318
[TBL] [Abstract][Full Text] [Related]
49. Current status of antihypertensive prescription and associated blood pressure control in Japan.
Mori H; Ukai H; Yamamoto H; Saitou S; Hirao K; Yamauchi M; Umemura S
Hypertens Res; 2006 Mar; 29(3):143-51. PubMed ID: 16755149
[TBL] [Abstract][Full Text] [Related]
50. Current prescription status of antihypertensive drugs in Japanese patients with hypertension: Analysis by type of comorbidities.
Ishida T; Oh A; Hiroi S; Shimasaki Y; Tsuchihashi T
Clin Exp Hypertens; 2019; 41(3):203-210. PubMed ID: 29781721
[TBL] [Abstract][Full Text] [Related]
51. Antihypertensive treatment for hypertensive patients with heart failure using real-world Japanese data: subanalysis of the Retrospective study of antihypertensives for lowering blood pressure (REAL) study.
Ohishi M; Yoshida T; Nishigaki N; Oh A; Shimasaki Y
Clin Exp Hypertens; 2020; 42(2):139-145. PubMed ID: 30912679
[TBL] [Abstract][Full Text] [Related]
52. Prevalence and predictors of resistant hypertension in a primary care setting: a cross-sectional study.
Chia YC; Ching SM
BMC Fam Pract; 2014 Jul; 15():131. PubMed ID: 24997591
[TBL] [Abstract][Full Text] [Related]
53. Retrospective analysis of real-world efficacy of angiotensin receptor blockers versus other classes of antihypertensive agents in blood pressure management.
Petrella R; Michailidis P
Clin Ther; 2011 Sep; 33(9):1190-203. PubMed ID: 21885126
[TBL] [Abstract][Full Text] [Related]
54. Blood pressure and low-density lipoprotein cholesterol control status in Chinese hypertensive dyslipidemia patients during lipid-lowering therapy.
Yan X; Li Y; Dong Y; Wu Y; Li J; Bian R; Hu D
Lipids Health Dis; 2019 Jan; 18(1):32. PubMed ID: 30696435
[TBL] [Abstract][Full Text] [Related]
55. Lab monitoring and acute care utilization during initiation of renin angiotensin aldosterone inhibitors or diuretics in chronic kidney disease.
Garlo KG; Bates DW; Seger DL; Fiskio JM; Charytan DM
Medicine (Baltimore); 2019 Dec; 98(49):e17963. PubMed ID: 31804307
[TBL] [Abstract][Full Text] [Related]
56. Diuretic or Beta-Blocker for Hypertensive Patients Already Receiving ACEI/ARB and Calcium Channel Blocker.
Tsai MS; Tang CH; Lin CY; Chuang PY; Chen NC; Huang CH; Chang WT; Wang TD; Yu PH; Chen WJ
Cardiovasc Drugs Ther; 2017 Dec; 31(5-6):535-543. PubMed ID: 29218625
[TBL] [Abstract][Full Text] [Related]
57. Lessons from the African-American Study of Kidney Disease and Hypertension: an update.
Toto RD
Curr Hypertens Rep; 2006 Oct; 8(5):409-12. PubMed ID: 16965728
[TBL] [Abstract][Full Text] [Related]
58. Frequency and Patterns of Prescribing Antihypertensive Agents in Outpatient Kidney Transplant Recipients Among Six Cities in China from 2011 to 2018.
Hou W; Li D; Shen S; Lin J; Lou A; Wen A
Clin Ther; 2021 Mar; 43(3):602-612. PubMed ID: 33637331
[TBL] [Abstract][Full Text] [Related]
59. Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for adults with early (stage 1 to 3) non-diabetic chronic kidney disease.
Sharma P; Blackburn RC; Parke CL; McCullough K; Marks A; Black C
Cochrane Database Syst Rev; 2011 Oct; (10):CD007751. PubMed ID: 21975774
[TBL] [Abstract][Full Text] [Related]
60. Antihypertensive treatment and risk of atrial fibrillation: a nationwide study.
Marott SC; Nielsen SF; Benn M; Nordestgaard BG
Eur Heart J; 2014 May; 35(18):1205-14. PubMed ID: 24347316
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
